Aravind Asokan, PhD, Professor in Surgery, and his team will collaborate with Danaher Corporation, a global science and technology innovator, for the first "Danaher Beacon for Gene Therapy Innovation."
Dr. Asokan will lead the innovation focusing on "product solutions that address bottlenecks impacting viral vector manufacturing yield and quality."